Keywords: مهار کننده فارنزیل ترانسفراز; CAPRI; Ca2+-promoted RAS inactivator; CRMP-2; collapsin response mediator protein-2; CSRD; cysteine/serine-rich domain; CTD; C-terminal domain; ERK; extracellular signal-regulated kinase; FTI; farnesyltransferase inhibitor; FAK1; focal adhesion kinase 1;
مقالات ISI مهار کننده فارنزیل ترانسفراز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده فارنزیل ترانسفراز; Glioblastoma; Treatment; Review; Pharmacology; Targeted therapy; Stem cell; AKT; protein kinase B; BBB; blood-brain barrier; BCNU; carmustin; CCNU; lomustin; c-MET; hepatocyte growth factor receptor; EGF(R); epidermal growth factor (receptor); EGFRvIII; e
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; Phenothiazine; Peptide coupling; Activated ester;
Keywords: مهار کننده فارنزیل ترانسفراز; FT; farnesyltransferase; SHR; spontaneously hypertensive rat; WKY; Wistar-Kyoto rat; FTI; farnesyltransferase inhibitor; ERK1/2; extracellular-signal regulated kinases 1/2; FPP; farnesyl pyrophosphate; MVA; mevalonate; TGF-β1; transforming growth factor-
Keywords: مهار کننده فارنزیل ترانسفراز; ATP5C1; ATP synthase, HÂ + transporting, mitochondrial F1 complex, gamma polypeptide; ATP5O; ATP synthase, HÂ + transporting, mitochondrial F1 complex, O subunit; ATP5B; ATP synthase, HÂ + transporting, mitochondrial F1 complex, beta polypeptide; ATP5A1;
New indolizine–chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; Phenothiazine; Chalcone; Indolizine; Antitumor agent
Simvastatin inhibits CD44 fragmentation in chondrocytes
Keywords: مهار کننده فارنزیل ترانسفراز; Chondrocyte; Pericellular matrix; Statin; CD44; Lipid raft; ADAM10; HA; hyaluronan; OA; osteoarthritis; OSM; Oncostatin M; BAC; bovine articular chondrocytes; HAC; human articular chondrocytes; MT1-MMP; membrane type I metalloproteinase; ICD; intracellula
Simvastatin induces insulin resistance in L6 skeletal muscle myotubes by suppressing insulin signaling, GLUT4 expression and GSK-3β phosphorylation
Keywords: مهار کننده فارنزیل ترانسفراز; Simvastatin; Glucose uptake; Glucose transporter 4; IR-Dependent IRS-1/PI3K/Akt pathway; L6 myotubes; FPP; farnesyl pyrophosphate; FTI; farnesyltransferase inhibitor; GGPP; geranylgeranyl pyrophosphate; GGTI; geranylgeranyltransferase 1 inhibitor; GLUT4;
Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432
Keywords: مهار کننده فارنزیل ترانسفراز; Tipifarnib; Farnesyltransferase inhibitor; Acute myeloid leukemia; Older; Untreated
Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase
Keywords: مهار کننده فارنزیل ترانسفراز; Indolizine; Farnesyltransferase inhibitor; Activated ester; Propargyl ester; Butynyl ester; Propargyl amide;
Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; N-Ylide; Phenothiazine; Anticancer agent;
Farnesyltransferase inhibitor attenuates methamphetamine toxicity-induced Ras proteins activation and cell death in neuroblastoma SH-SY5Y cells
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; Methamphetamine; Ras activation; Neuronal cells; Cell death;
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice
Keywords: مهار کننده فارنزیل ترانسفراز; Mevalonate pathway; Farnesyltransferase inhibitor; Chronic renal failure; Calcification; Atherosclerosis; apoEâ/â mouse;
New farnesyltransferase inhibitors in the phenothiazine series
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; Anticancer agent; Phenothiazine; Triazole
Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; Phenothiazine; Pyrazole; Pyrazoline; Acylhydrazone; Cytostatic agent;
Cytoprotective effect of the small GTPase RhoB expressed upon treatment of fibroblasts with the Ras-glucosylating Clostridium sordellii lethal toxin
Keywords: مهار کننده فارنزیل ترانسفراز; FTI; farnesyltransferase inhibitor; MEF; mouse embryonic fibroblasts; TcdBF; toxin B from the Clostridium difficile serotype F strain 1470; TcsL; lethal Toxin from Clostridium sordellii; TUDCA; tauroursodesoxycholic acid; Glucosyltransferase; Apoptosis; C
A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma
Keywords: مهار کننده فارنزیل ترانسفراز; Tipifarnib; Newly diagnosed glioblastoma; Radiation; Farnesyltransferase inhibitor; Temozolomide;
Combination of tipifarnib and rapamycin synergistically inhibits the growth of leukemia cells and overcomes resistance to tipifarnib via alteration of cellular signaling pathways
Keywords: مهار کننده فارنزیل ترانسفراز; Tipifarnib; Farnesyltransferase inhibitor; Rapamycin; K562; K562/RR; Leukemia
Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer
Keywords: مهار کننده فارنزیل ترانسفراز; Patient-reported outcomes; pancreatic cancer; farnesyltransferase inhibitor
Pravastatin improves renal ischemia–reperfusion injury by inhibiting the mevalonate pathway
Keywords: مهار کننده فارنزیل ترانسفراز; ischemia–reperfusion injury; the mevalonate pathway; pravastatin; apolipoprotein E knockout mouse; farnesyltransferase inhibitor
Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; Lonafarnib; Paclitaxel; Ovarian cancer
Phase I Trial of Tipifarnib (R115777) Concurrent With Radiotherapy in Patients with Glioblastoma Multiforme
Keywords: مهار کننده فارنزیل ترانسفراز; Tipifarnib; Radiotherapy; Farnesyltransferase inhibitor; Glioblastoma; Phase I;
Farnesyltransferase inihibitors in hematologic malignancies
Keywords: مهار کننده فارنزیل ترانسفراز; Acute myeloid leukemia; Chronic myeloid leukemia; Farnesyltransferase inhibitor; Multiple myeloma; Myelodysplastic syndrome; Tipifarnib; Lonafarnib
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors
Keywords: مهار کننده فارنزیل ترانسفراز; Farnesyltransferase inhibitor; BMS-316810;
Relative importance of apoptosis and cell cycle blockage in the synergistic effect of combined R115777 and imatinib treatment in BCR/ABL-positive cell lines
Keywords: مهار کننده فارنزیل ترانسفراز; R115777; Farnesyltransferase inhibitor; Imatinib; BCR/ABL; Chronic myeloid leukemia; Drug resistance;